Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |